Cubist Pharmaceuticals : CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Merck & Co.

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc. (NasdaqGS: CBST) (“Cubist”) in connection with the sale of the Company to Merck & Co.

Click here to learn about the case: http://docs.wongesq.com/CBST-Info-Request-Form-509. There is no cost or obligation to you.

Under the terms of the transaction, Cubist Pharmaceuticals shareholders will receive $102.00 for each share of Cubist Pharmaceuticals stock they own. The investigation concerns whether the Board of Cubist Pharmaceuticals breached their fiduciary duty to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Merck & Co. is underpaying for Cubist Pharmaceuticals shares.

If you own common stock in Cubist Pharmaceuticals and wish to obtain additional information, please contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/CBST-Info-Request-Form-509.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.